Michele J. Orza, ScD, is the Chief of Staff at the Patient-Centered Outcomes Research Institute (PCORI). Before PCORI, she was a principal policy analyst at the National Health Policy Forum focused on evidence-based health practice and policy, public health infrastructure and systems, global health, and health science and technology. Previously, Orza was a scholar at the Institute of Medicine (IOM) with the Board on Global Health, where she served as study director for the President’s Emergency Plan for AIDS Relief (PEPFAR) Evaluation. While at the IOM, she also served as acting director of the Board on Health Care Services. Prior to that, she served as assistant director of the Health Care Team at the Government Accountability Office, where she was responsible for managing study teams evaluating a wide range of federal health programs.
For several years, she also served as director of science and research at the American College of Cardiology, where her department was responsible for supporting the college’s evidence-based medicine activities. Before coming to Washington, DC, Orza worked as a research assistant in the Technology Assessment Group at the Harvard School of Public Health on a wide variety of methods for and applications of systematic reviews and meta-analysis and other tools to promote and support evidence-based public health. Orza has served as a member of the Advisory Board to the Johns Hopkins Center for Health Policy and Healthcare Transformation, as Consumer Representative on the U.S. Food and Drug Administration’s Advisory Committee for Reproductive Health Drugs, and currently serves on two IOM Committees: the Standing Committee to Support USAID’s Engagement in Health Systems Strengthening in Response to the Economic Transition of Health and the Committee for the Evaluation of the Impact of the IOM’s Report The Future of Nursing: Leading Change, Advancing Health. She received both her master’s degree in health policy and management and her doctorate in program evaluation from the Harvard School of Public Health and received the first BA degree in women’s studies from Harvard/Radcliffe University.
Conflict of Interest Disclosures
As of May 24, 2020
Financial or Business Associations:
- None reported
- National Academy of Medicine, Committee member
- U.S. Food and Drug Administration, Committee member